9th Original Forum on CRM for the Bio/Pharmaceutical Industry

Relationship Marketing is one of closerlook’s core service offerings, and at CBI’s 9th Annual Forum on CRM for the Bio/Pharmaceutical Industry, David Ormesher presented key insights into our proprietary Information Strategy methodology.

The conference was held on October 16–17, 2006 in New York City.

Drive CRM Value through a Coherent Information Strategy

Behind every successful CRM program is a coherent information strategy. It’s not enough to simply react as data from existing customer-facing activities flows into a database. A passive information approach increases the value of existing disparate sales and marketing data, but it overlooks the chance to use your CRM technology infrastructure proactively to gather the customer information your organization will value the most. The best practice for a coherent information strategy includes a plan for learning about your customer, integrating “Golden Questions” seamlessly into customer interactions at all touchpoints, and using information immediately to drive customer experience. This increased personalization drives additional CRM value by extending beyond the status quo from relationship management into relationship building.

• Explore how to profile an audience as the first step to a successful information strategy
• Review how proactive CRM can drive internal adoption
• See how to leverage leading CRM applications to execute an information strategy through technology extension
• Review examples of enhanced data models that can accommodate golden questions
• Examine best practice web-based reporting applications

9th Original Forum on Customer Relationship Management (CRM) for the Bio/Pharmaceutical Industry

Integrated Relationship Marketing and Multi-Channel Communication Strategies for Market Optimization

October 16 – 17, 2006
Brooklyn, NY

Pharmaceutical companies continue to grapple with finding new ways to make sales forces more effective and have continued to turn to customer relationship management. AMR Research reports that 35% of companies in a survey cited CRM investments as a top priority in 2005, up from 26% in 2004.

The 2006 conference provided executives in the Bio/Pharmaceutical industry with high-level coverage on the business drivers and operational components that need to be in place in order to optimize CRM initiatives. Learn how to improve the customer experience and be able to measure and track the effectiveness through innovative customer strategies, change management and IT structure.